Risk factors for incomplete excision of cutaneous squamous cell carcinoma: a large cohort study

التفاصيل البيبلوغرافية
العنوان: Risk factors for incomplete excision of cutaneous squamous cell carcinoma: a large cohort study
المؤلفون: N. Marsidi, R. Ottevanger, J.N. Bouwes Bavinck, N.M.A. Krekel ‐ Taminiau, J.J. Goeman, R.E. Genders
المصدر: Journal of the European Academy of Dermatology and Venereology, 36(8), 1229-1234. WILEY
بيانات النشر: Wiley, 2022.
سنة النشر: 2022
مصطلحات موضوعية: Cohort Studies, Skin Neoplasms, Infectious Diseases, Risk Factors, Carcinoma, Squamous Cell, Humans, Dermatology, Neoplasm Recurrence, Local, Neoplasm Staging, Retrospective Studies
الوصف: Background The standard treatment for cutaneous squamous cell carcinoma (cSCC) is surgical excision. Failure to radically remove a cSCC is a risk for recurrence, progression and metastasis. Objectives This study investigates several risk factors for incomplete excision of cSCC. Methods All consecutive patients in a single institution treated with wide local excision for primary cSCC over a 10-year period were included in this study. Risk factors such as: gender, age, immunosuppression, tumour size, location, differentiation grade, tumour depth, perineural and lymphovascular invasion (PNI and LVI) were extracted from the database. Univariable and (if applicable) multivariable logistic regression analysis were used to identify risk factors (P < 0.05). Generalized estimating equations (GEEs) were used for multiple tumours within the same patients. Results A total of 566 patients with 1159 cSCC were identified. Univariable and multivariable logistic regression analysis showed that depth beyond the dermis (OR: 5.7 95% CI: 3.1-10.5) was the only risk factor for incomplete excision of cSCC. Immunosuppression was only a risk factor in the deep plane (OR: 2.5, 95% CI: 1.3-4.6). Conclusion Tumour depth beyond the dermis is the most important risk factor for incomplete excision of cSCC. Immunosuppression is a risk factor in the deep plane but its relevance is uncertain. Immunosuppression is not consistently included in the current cSCC staging systems, but care should be taken when treating these patients.
تدمد: 1468-3083
0926-9959
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d56b987d8c999a63ca079239c1e94bb1Test
https://doi.org/10.1111/jdv.18101Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....d56b987d8c999a63ca079239c1e94bb1
قاعدة البيانات: OpenAIRE